IOP Reduction in Pigmentary Glaucoma Using DSLT — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

IOP Reduction in Pigmentary Glaucoma Using DSLT — Stella

Recruiting

Back to Pigmentary Dispersion Syndrome trials

Trial locations(1 site)

United States

Mann Eye Institute, Houston, Texas

Key details

Sponsor

Mann Eye Institute

Collaborators

Sengi

Enrollment target

~45 participants

Started

March 2026

Primary completion

April 2027

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov